The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Matsuda Masaru since 2020.
This trader's CIK number is 1798679.
At the time of last reporting, Matsuda Masaru was the See Remarks of Arcutis Biotherapeutics, Inc.. (stock ticker symbol ARQT).
Also see all insider trading activities at Arcutis Biotherapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | HALO | 0 | $0 | 0 | $0 | 17,269 | $0 |
| 2020 | HALO | 0 | $0 | 0 | $0 | 11,014 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ARQT | 0 | $0 | 24,761 | $340,362 | 0 | $0 |
| 2024 | ARQT | 5,657 | $18,542 | 18,801 | $167,619 | 0 | $0 |
| 2023 | ARQT | 0 | $0 | 5,114 | $41,124 | 0 | $0 |
| 2022 | ARQT | 0 | $0 | 3,515 | $66,706 | 0 | $0 |
1. Halozyme Therapeutics, Inc. (HALO)
2. Arcutis Biotherapeutics, Inc. (ARQT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-09-04 | HALO | Option Ex | 6,883 | .00 | 0 |
| 2021-02-10 | HALO | Option Ex | 6,257 | .00 | 0 |
| 2021-02-12 | HALO | Option Ex | 4,129 | .00 | 0 |
| 2020-09-04 | HALO | Option Ex | 6,884 | .00 | 0 |
| 2020-02-12 | HALO | Option Ex | 4,130 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-04 | ARQT | Sale | 6,330 | 14.33 | 90,689 |
| 2025-05-28 | ARQT | Sale | 1,800 | 13.78 | 24,805 |
| 2025-05-02 | ARQT | Sale | 5,030 | 15.20 | 76,456 |
| 2025-03-03 | ARQT | Sale | 3,263 | 13.03 | 42,520 |
| 2025-02-03 | ARQT | Sale | 8,338 | 12.70 | 105,892 |
| 2024-11-30 | ARQT | Buy | 1,657 | 7.11 | 11,774 |
| 2024-05-31 | ARQT | Buy | 4,000 | 1.69 | 6,768 |
| 2024-11-19 | ARQT | Sale | 1,775 | 9.69 | 17,190 |
| 2024-11-04 | ARQT | Sale | 5,015 | 8.68 | 43,550 |
| 2024-08-02 | ARQT | Sale | 5,220 | 9.02 | 47,063 |
| 2024-05-28 | ARQT | Sale | 1,775 | 9.01 | 15,987 |
| 2024-05-02 | ARQT | Sale | 5,016 | 8.74 | 43,829 |
| 2023-11-21 | ARQT | Sale | 1,850 | 1.98 | 3,661 |
| 2023-05-31 | ARQT | Sale | 1,830 | 7.80 | 14,277 |
| 2023-03-02 | ARQT | Sale | 1,434 | 16.17 | 23,186 |
| 2022-11-21 | ARQT | Sale | 1,720 | 18.19 | 31,288 |
| 2022-06-02 | ARQT | Sale | 1,795 | 19.73 | 35,418 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Matsuda Masaru (See Remarks of Arcutis Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.